The perspective of celiac disease patients on emerging treatment options and non-celiac gluten sensitivity.

Details

Serval ID
serval:BIB_6B802A508658
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
The perspective of celiac disease patients on emerging treatment options and non-celiac gluten sensitivity.
Journal
Digestive and liver disease
Author(s)
Greuter T., Schmidlin S., Lattmann J., Stotz M., Lehmann R., Zeitz J., Scharl M., Misselwitz B., Pohl D., Fried M., Tutuian R., Fasano A., Schoepfer A.M., Rogler G., Biedermann L., Vavricka S.R.
ISSN
1878-3562 (Electronic)
ISSN-L
1590-8658
Publication state
Published
Issued date
03/2017
Peer-reviewed
Oui
Volume
49
Number
3
Pages
268-272
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
Non-celiac gluten sensitivity (NCGS) and emerging treatment options are hot topics in the celiac disease (CeD) scientific literature. However, very little is known about the perspective on these issues of CeD patients.
We performed a large patient survey among unselected CeD patients in Switzerland.
A total of 1689 patients were analyzed. 57.5% have previously heard of NCGS. 64.5% believe in the existence of this entity. Regarding a potential influence of NCGS on CeD awareness, 31.7% show a positive and 27.5% a negative perception. Patients with prior use of alternative medicine and women more often have heard of and believe in the existence of NCGS vs. those never having used alternative methods and men, respectively (66.9 vs. 56.9%, p=0.001 and 78.5 vs. 69.0%, p=0.001; 60.7 vs. 44.2%, p<0.001 and 71.0 vs. 60.8%, p=0.002). Women and patients ≥30 years more often show a negative attitude towards NCGS (32.2% vs. 24.8%, p=0.024 and 32.2% vs. 24.2%, p=0.018). With regard to emerging treatment options for CeD, 43.3% have previously heard of novel agents, more women than men (46.0 vs. 38.0%, p=0.019).
Perception of and attitude towards NCGS differ depending on sex, age and prior use of alternative medicine. Knowledge of the progress towards emerging treatment options is currently limited.

Pubmed
Web of science
Create date
10/01/2017 19:38
Last modification date
20/08/2019 15:25
Usage data